JCM Accepts, published online ahead of print on 28 October 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Kvach, E. J.
Right arrow Articles by Landry, M. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kvach, E. J.
Right arrow Articles by Landry, M. L.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.01630-09
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Comparison of BD GeneOhm Cdiff Real-time PCR Assay with a Two-Step Algorithm and a Toxin A/B ELISA for Diagnosis of Toxigenic Clostridium difficile Infection

Elizabeth J. Kvach, David Ferguson, Paul F. Riska, and Marie L. Landry*

Department of Laboratory Medicine, Yale University School of Medicine, and Clinical Virology Laboratory, Yale-New Haven Hospital, New Haven, CT; and Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY

* To whom correspondence should be addressed. Email: marie.landry{at}yale.edu.


arrow
Abstract

BD GeneOhmTM Cdiff assay, a real-time PCR assay for the detection of Clostridium difficile toxin B (tcdB) gene, was compared with Tox A/B IITM ELISA and a two-step algorithm which includes C. Diff Chek-60TM Glutamate Dehydrogenase (GDH)-antigen assay followed by cytotoxin neutralization. Four-hundred liquid or semisolid stools submitted for diagnostic C. difficile testing were selected: 200 GDH antigen-positive and 200 GDH antigen-negative. All samples were tested by the C. Diff Chek-60TM GDH antigen, cytotoxin neutralization, Toxin A/B IITM ELISA, and BD GeneOhmTM Cdiff assay. Discrepant specimens were tested by toxigenic culture as an independent gold standard. Of 200 GDH-positive samples, 71 were positive by Tox A/B II, 88 were positive by the two-step method, 93 were positive by PCR, and 96 were positive by GDH-antigen only. Of 200 GDH-negative samples, 3 were positive by PCR only. Toxigenic culture was performed on 41 samples with discrepant results and 39 were culture-positive. After culture resolution of discrepants, Tox A/B II detected 70 (66.7%), the two-step method detected 87 (82.9%), and PCR detected 96 (91.4%) of 105 true positives. The BD Gene-OhmTM Cdiff assay was more sensitive in detecting toxigenic C. difficile than Tox A/B II (p <0.0001); however, the difference between PCR and the two-step method was not significant (p=0.1237). Enhanced sensitivity and rapid turnaround time make the BD GeneOhmTM Cdiff assay an important advance in the diagnosis of toxigenic C. difficile infection.